| Metric | შპს Krol Medical Corporation | სს ვერე XXI |
|---|---|---|
| Growth | ||
| Revenue | ₾573k₾1.1m | ₾928k₾821k |
| Revenue growth | -47.4% | 13.1% |
| Profitability | ||
| EBITDA | -₾272k₾265k | -₾29k-₾67k |
| EBITDA margin | -47.5%24.3% | -3.1%-8.2% |
| Net profit | -₾272k₾265k | -₾83k-₾115k |
| Net margin | -47.5%24.3% | -9.0%-14.0% |
| Balance sheet | ||
| Total assets | ₾1.6m₾1.8m | ₾2.1m₾1.9m |
| Total equity | ₾1.2m₾1.2m | ₾1.3m₾1.4m |
| ROE | -23.3%22.6% | -6.5%-8.4% |